Viewing Study NCT01319903


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2025-12-27 @ 11:05 PM
Study NCT ID: NCT01319903
Status: COMPLETED
Last Update Posted: 2012-01-13
First Post: 2011-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29
Sponsor: InflaRx GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module